TRUFU: Therapeutic Radiographer undertaking Follow Up for Prostate Cancer Patients

Stacey Hetherington, Terri Gilleece, Paul Shepherd, Karen Crowther, J O'Sullivan, S Jain, D Mitchell, L Schum, P Turner

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
26 Downloads (Pure)


A study was proposed to examine the impact to patients and the Oncology review team, of extending the role of the Therapeutic Radiographer to undertake follow up review of prostate cancer patients who have completed a radical course of external beam radiotherapy treatment.

A total of 30 patients attending for routine radiotherapy follow up were included in an observational study. Patients were assigned for review with a Doctor or a Therapeutic Radiographer using 1:1 randomisation and a number of time points were recorded and analysed.

Of the 44 patients screened, 30 patients were recruited. Average time from scheduled appointment time to departure from clinic was 36 min for both the doctor and Therapeutic Radiographer. The average length of Consultation was 19 min for the Therapeutic Radiographer and 10 min for the Doctor. Average length of wait for patients from scheduled appointment time to being taken for review was 17 min for the Therapeutic Radiographer and 25 min for the Doctor. Of the patients who completed questionnaires, 23/28 had no preference of reviewer, 2/28 declared a preference to be seen by a doctor, whilst 3/28 stated a preference for review with a Therapeutic Radiographer.

The results of the study are encouraging and should be further investigated in an attempt of developing what would be a very rewarding aspect of the Therapeutic Radiographers role.
Original languageEnglish
Pages (from-to)298-303
Number of pages6
Issue number4
Early online date4 Jul 2018
Publication statusPublished (in print/issue) - 1 Nov 2018


  • oncology
  • Patient management
  • observational study
  • patient satisfaction
  • Role development


Dive into the research topics of 'TRUFU: Therapeutic Radiographer undertaking Follow Up for Prostate Cancer Patients'. Together they form a unique fingerprint.

Cite this